Absolutely best possible outcome , adult trial is likely to get the green light too… resubmission and AA for LVAD… very interesting end of 2024 and start of 2025
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-73
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.033(2.89%) |
Mkt cap ! $1.275B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.14 | $1.09 | $3.376M | 3.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 7883 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 19602 | 10 |
View Market Depth
| Last trade - 14.43pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
-0.033 ( 3.89 %) |
||||
| Open | High | Low | Volume | ||
| $1.13 | $1.14 | $1.07 | 804705 | ||
| Last updated 15.04pm 05/06/2024 ? | |||||
| MSB (ASX) Chart |